Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

News > All

Total search results: 9848 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 29 30 31 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Mologen AG. (12/21/16). "Press Release: Public Rights Offering of Convertible Bonds with Purchase Guarantee by Major Shareholder. Issue volume €4.99 million, Maturity of 8 Years [Not for United States, Australia, Canada or Japan, et al.]". Berlin. 2016-12-21
Protagen AG. (12/20/16). "Press Release: Protagen AG Successfully Joined Forces with Novartis to Support Clinical Development of a Novel Compound in an Autoimmune Indication". 2016-12-20
Pharnext S.A.. (12/20/16). "Press Release: Pharnext Completes Patient Enrollment in International Pivotal Phase 3 Trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1A". Paris. 2016-12-20
Mundipharma International Ltd.. (12/20/16). "Press Release: CHMP Announces Positive Opinion for Biosimilar Rituximab Truxima and Mundipharma Has Secured Distribution Rights". Cambridge. 2016-12-20
TiGenix N.V.. (12/20/16). "Press Release: Takeda Makes €10 Million Equity Investment in TiGenix". Leuven. 2016-12-20
Kuros Biosciences Ltd.. (12/19/16). "Press Release: Kuros to Acquire Xpand in an All-share Strategic Transaction to Create a Leading Commercial Stage Orthobiologics Company". Schlieren. 2016-12-19
SGS S.A.. (12/19/16). "Press Release: SGS Acquires Control of C-Labs SA, Switzerland". 2016-12-19
Novartis AG. (12/16/16). "Press Release: Novartis Bolsters Innovative Dermatology Portfolio through Acquisition of Ziarco Group Limited". Basel. 2016-12-16
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Bruker Corporation. (12/16/16). "Press Release: Bruker Announces Acquisition of Active Spectrum Micro-ESR Business". Billerica, MA. 2016-12-16
Merck KGaA. (12/16/16). "Press Release: Merck and the European Space Agency Extend Collaboration to Foster Innovation, Digitalization". Darmstadt. 2016-12-16
Bluebird Bio, Inc.. (12/15/16). "Press Release: Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement". Cambridge, MA & Munich. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec Completes Acquisition of Cyprotex plc". Hamburg. 2016-12-15
Evotec AG. (12/15/16). "Press Release: Evotec and Celgene Enter into Drug Discovery Collaboration for Neurodegenerative Diseases". Hamburg. 2016-12-15
Valneva S.E.. (12/15/16). "Press Release: Valneva Confirms Closing of Private Placement in Connection with €15.2m Investment by MVM Life Science Partners". Lyon. 2016-12-15
Noxxon Pharma N.V.. (12/15/16). "Press Release: Noxxon Pharma Signs Clinical Immuno-oncology Collaboration Agreement with MSD to Study NOX-A12 Combined with Keytruda (pembrolizumab) in Pancreatic and Colorectal Cancer". Berlin. 2016-12-15
Lonza Group Ltd.. (12/15/16). "Press Release: Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel & Morristown, NJ. 2016-12-15
Univercells S.A.. (12/15/16). "Press Release: Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform". Brussels. 2016-12-15
Acousia Therapeutics GmbH. (12/14/16). "Press Release: Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss". Tübingen. 2016-12-14
Tecan Group Ltd.. (12/14/16). "Press Release: Tecan Announces Change in Management Board". Männedorf. 2016-12-14
High-Tech Gründerfonds Management GmbH. (12/14/16). "Press Release: Chinese Biotech Investor Viroad Takes Over Gilupi". 2016-12-14
Amcure GmbH. (12/14/16). "Press Release: Amcure Raises €6 Million in Series B Financing and Expands Advisory Board". Eggenstein-Leopoldshafen. 2016-12-14
AMSilk GmbH. (12/14/16). "Press Release: Biosteel Fibers from AMSilk Receive Certification for product Safety and Confirmation of Biological Degradability". Planegg. 2016-12-14
Genome Diagnostics B.V. (GenDx). (12/13/16). "Press Release: GenDx Signs Reseller Agreement with Illumina". Utrecht. 2016-12-13
Bayer AG. (12/13/16). "Press Release: Monsanto Shareowners Approve Merger with Bayer". St. Louis, MO. 2016-12-13
MorphoSys AG. (12/13/16). "Press Release: MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor". 2016-12-13
Curetis N.V.. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Protagen AG. (12/13/16). "Press Release: Protagen Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases". 2016-12-13
Carpegen GmbH. (12/13/16). "Press Release: Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec". Amsterdam & Holzgerlingen. 2016-12-13
Bayer AG. (12/12/16). "Press Release: Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing". Leverkusen, et al.. 2016-12-12
Bayer AG. (12/12/16). "Press Release: Robert LaCaze to be Executive Vice President of New Oncology Strategic Business Unit at Pharmaceuticals Division of Bayer". Leverkusen. 2016-12-12
MolMed S.p.A.. (12/12/16). "Press Release: MolMed Coordinates a CAR T-cell Immunotherapy Project Awarded a 5.9 million Euro Grant by the European Commission". Milan. 2016-12-12
Novartis AG. (12/12/16). "Press Release: Novartis Provides Update on Pegpleranib Phase III Clinical Trial Program in Patients with Neovascular Age-related Macular Degeneration (nAMD or wet AMD)". Basel. 2016-12-12
Curetis N.V.. (12/12/16). "Press Release: #investEU – Curetis Obtains EIB Debt Financing Totaling up to EUR 25 Million to Further Expand Its Diagnostic Platform". Amsterdam, Holzgerlingen & Luxembourg. 2016-12-12
Evotec AG. (12/9/16). "Press Release: Evotec and Forge Therapeutics Form Strategic »Superbug« Alliance". Hamburg. 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Opens New Agriculture and Food Testing Laboratory in South Korea". 2016-12-09
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
Inflazome Ltd.. (9/12/16). "Press Release: Inflazome Closes Series A Financing". Dublin. 2016-12-09
Probiodrug AG. (12/8/16). "Press Release: Innovative Phase II Study Design of Glutaminylcyclase Inhibitor PQ912 in Early Alzheimer’s disease". Halle (Saale). 2016-12-08
Singulex, Inc.. (12/8/16). "Press Release: Singulex and Thermo Fisher Scientific Enter into License and Supply Agreement to Bring Next Generation Immunodiagnostics to Sepsis and SIRS Diagnostics". Alameda, CA. 2016-12-08
Merck KGaA. (12/8/16). "Press Release: Merck Appoints Thomas Möller as New Head of External Communications". Darmstadt. 2016-12-08
Numares AG. (12/8/16). "Press Release: Numares AG Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia". Regensburg. 2016-12-08
TCR2 Therapeutics Inc.. (12/7/16). "Press Release: TCR2 Therapeutics Launches from Stealth Mode to Accelerate Development of Novel Cancer Immunotherapies. $44.5M Series A Financing Led by MPM Capital and F2 Ventures". Cambridge, MA. 2016-12-07
Nordic Nanovector ASA. (12/7/16). "Press Release: Nordic Nanovector – Private Placement Successfully Completed [Not for the United States of America, Canada, Japan or Australia]". Oslo. 2016-12-07
Bayer AG. (12/7/16). "Press Release: Boehringer Ingelheim Vetmedica, Inc. and Bayer Enter into Agreement for Purchase of U.S. Cydectin Product Portfolio". Shawnee, KS. 2016-12-07
Ayoxxa Biosystems GmbH. (12/7/16). "Press Release: Ayoxxa Appoints Permanent CEO". Cologne. 2016-12-07
AstraZeneca plc. (12/6/16). "Press Release: Tagrisso Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-positive Non-small Cell Lung Cancer". 2016-12-06
MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016". 2016-12-06
MorphoSys AG. (12/6/16). "Press Release: MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference". 2016-12-06
Affimed N.V.. (12/6/16). "Press Release: Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH". Heidelberg. 2016-12-06
Merck KGaA. (12/6/16). "Press Release: Merck’s Consumer Health Business Drives Consumer-centric, Purposeful Innovation". Darmstadt. 2016-12-06
AstraZeneca plc. (12/5/16). "Press Release: AstraZeneca Completes Agreement With Cilag GmbH International for Rights to Rhinocort Aqua Outside the US". 2016-12-05
Novimmune S.A.. (12/5/16). "Press Release: Novimmune Grants Genentech an Exclusive Option to License NI-0101, its anti-TLR4 Monoclonal Antibody for the Treatment of Rheumatoid Arthritis". Geneva. 2016-12-05
Bayer AG. (12/5/16). "Press Release: Bayer and FaunaPhotonics Form Research Collaboration to Develop Sensor Technology for Improved Monitoring of Insect Pests". Monheim. 2016-12-05
Merck KGaA. (12/5/16). "Press Release: Merck to Provide Provantage End-to-End Services to Acticor Biotech SAS". Darmstadt. 2016-12-05
InGeneron Inc.. (12/5/16). "Press Release: German Accelerator Life Sciences. InGeneron Establishes Presence in Cambridge, MA and Initiates Collaboration with German Accelerator Life Sciences". Cambridge, MA & Berlin. 2016-12-05
Biomunex Pharmaceuticals SASU. (12/5/16). "Press Release: Biomunex Appoints Dr. Sebastian Amigorena and Dr. Dragan Grabulovski as Key Scientific and Strategic Advisors". Paris. 2016-12-05
Novartis AG. (12/3/16). "Press Release: Novartis SEG101 (Crizanlizumab, formerly SelG1) Significantly Reduces Frequency of Sickle Cell Pain Crises in Phase II Study". Basel. 2016-12-03
Bruker Corporation. (12/2/16). "Press Release: Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs". Billerica, MA. 2016-12-02
Apeptico Forschung und Entwicklung GmbH. (12/2/16). "Press Release: Apeptico and Mediolanum Sign a Research and Development Cooperation and License Agreement for Apeptico’s Therapeutic Peptide Solnatide". Vienna & Milano. 2016-12-02
Bellevue Group AG. (12/2/16). "Press Release: Successful Launch of BB Healthcare Trust plc on the London Stock Exchange – Initial Issue Volume GBP 150 Million [Not for US]". 2016-12-02
Merck KGaA. (12/2/16). "Press Release: Merck Introduces Milliplex High Sensitivity Panel for Faster, More Economical Cytokine Assays". Darmstadt. 2016-12-02
Merck KGaA. (12/2/16). "Press Release: Merck Launches Parteck MXP Excipient for Increased Solubility". Darmstadt. 2016-12-02
Valneva S.E.. (12/1/16). "Press Release: Leading Healthcare Investor MVM Life Science Partners Acquires 7.5% Shareholding in Valneva". Lyon. 2016-12-01
Pieris Pharmaceuticals, Inc.. (12/1/16). "Press Release: Pieris Pharmaceuticals Appoints Claude Knopf as Chief Business Officer". Boston, MA. 2016-12-01
AiCuris Anti-infective Cures GmbH. (12/1/16). "Press Release: AiCuris Announces Start of LipP 1 – First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes". Wuppertal. 2016-12-01
Merck KGaA. (12/1/16). "Press Release: Merck Expands Distribution Agreement with Roche". Darmstadt. 2016-12-01
Coulter Partners. (12/1/16). "Press Release: Coulter Partners Places Chief Financial Officer for Medigene AG". 2016-12-01
Zedira GmbH. (11/30/16). "Press Release: Zedira Receives Funding by the German Government for the Development of Transglutaminase Inhibitors for the Treatment of Diabetic Nephropathy". Darmstadt. 2016-11-30
Takeda Pharmaceutical Co. Ltd.. (11/30/16). "Press Release: Takeda to Invest more than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany". Konstanz & Osaka. 2016-11-30
Heptares Therapeutics Ltd.. (11/30/16). "Press Release: Heptares to Acquire G7 Therapeutics to Extend Leadership in GPCR-Focused Drug Discovery and Development". London & Zurich. 2016-11-30
Evotec AG. (11/30/16). "Press Release: Evotec and Merck Enter into Agreements to Collaborate on Target Discovery Technologies". Hamburg. 2016-11-30
Advanced Chemistry Development, Inc. (ACD/Labs). (11/30/16). "Press Release: Boehringer Ingelheim Selects ACD/Labs for International Deployment". Toronto, ON. 2016-11-30
Ionicon Analytik GmbH. (11/29/16). "Press Release: Ionicon Launches New High-resolution PTR-TOF 4000 Trace Gas Analyzer". Innsbruck. 2016-11-29
Themis Bioscience GmbH. (11/28/16). "Press Release: Themis Bioscience Successfully Closes 10 M EUR Financing Round". Vienna. 2016-11-29
International Phenome Centre Network (IPCN). (11/29/16). "Press Release: Global Research Network Hunts the Missing Link between Genetics and Environmental Factors to Unlock the Secrets of Global Diseases such as Cancer and Diabetes to Revolutionise Healt 2016-11-29
Evolva Holding S.A.. (11/29/16). "Press Release: Evolva Appoints Oliver Walker as CFO. Strong Track Record as CFO of Nobel Biocare, Sonova and Stratec". 2016-11-29
AudioCure Pharma GmbH. (11/29/16). "Press Release: AudioCure Completes Financing Round with MED-EL and HTGF". 2016-11-29
GeneWerk GmbH. (11/29/16). "Press Release: GenoSafe and GeneWerk Bundle Their Strengths. Both Companies Work Together in the Field of Gene and Cell Therapies". 2016-11-29
Addex Therapeutics S.A.. (11/28/16). "Press Release: Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer". Geneva. 2016-11-28
Agilent Technologies Inc.. (11/28/16). "Press Release: Agilent Technologies Presents Thought Leader Award to Influential Clinical Genomics Researcher". Santa Clara, CA. 2016-11-28
Bicycle Therapeutics Ltd.. (11/28/16). "Press Release: Bicycle Therapeutics to Present Preclinical Data at the 28th EORTC-NIC-AACR Molecular Targets and Cancer Therapeutics Symposium". Cambridge, MA & Cambridge. 2016-11-28
MorphoSys AG. (11/28/16). "Press Release: MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application For Guselkumab in Europe". 2016-11-28
Bruker Corporation. (11/28/16). "Press Release: Bruker AXS Introduces a New Member to the D8 ADVANCE Family — the D8 ADVANCE Plus". Boston, MA. 2016-11-28
Sygnis AG. (11/28/16). "Press Release: Sygnis AG Reinforces Its Proteomics Portfolio with Two Patents Granted in Europe and China". Madrid & Heidelberg. 2016-11-28
Actelion Ltd.. (11/25/16). "Press Release: Actelion Statement [on Possible Transaction with Johnson & Johnson]". Allschwil. 2016-11-25
AiCuris Anti-infective Cures GmbH. (11/23/16). "Press Release: AiCuris Announces U.S. NIH Support of Preclinical Study with AIC649". Wuppertal. 2016-11-23
AC Immune S.A.. (11/23/16). "Press Release: AC Immune Appoints Experienced Life Science Professional as New Chief Financial Officer". Lausanne. 2016-11-23
T3 Pharmaceuticals AG. (11/23/16). "Press Release: T3 Pharma Closes First Financing Round to Advance Research and Preclinical Development of Breakthrough Bacteria-based Cancer Therapies". Basel. 2016-11-23
Medigene AG. (11/22/16). "Press Release: Medigene Appoints Dr. Thomas Taapken as Chief Financial Officer". Martinsried. 2016-11-22
Proteros Biostructures GmbH. (11/22/16). "Press Release: Proteros Signs Second Oncology Collaboration with MSD on Epigenetic Target". Martinsried. 2016-11-22
Bruker Corporation. (11/22/16). "Press Release: Bruker Completes Acquisition of Preclinical PET Imaging Business". Billerica, MA. 2016-11-22
Novartis AG. (11/21/16). "Press Release: Novartis Acquires Selexys Pharmaceuticals Corporation and SelG1 Antibody for Reduction of Pain Crises in Sickle Cell Disease (SCD)". Basel. 2016-11-21
Deutsche Börse AG. (11/21/16). "Press Release: New SME Segment to Facilitate Access to Growth Capital for Enterprises. Launch Date Set for 1 March 2017". 2016-11-21
InGeneron Inc.. (11/21/16). "Press Release: Chronic Back Pain Series at IFATS. InGeneron Announces Presentation of Results from Investigator Initiated Case Series of its Regenerative Cell Therapy in Chronic Back Pain at IFATS". Houston, TX & Munich. 2016-11-21
Curetis N.V.. (11/18/16). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months 2016". Amsterdam & Holzgerlingen. 2016-11-18
Novartis AG. (11/18/16). "Press Release: Innovative Study with Three Treatment Switches Confirms Sandoz Biosimilar Etanercept Has Equivalent Efficacy to Originator". Holzkirchen. 2016-11-18
AMSilk GmbH. (11/18/16). "Press Release: Adidas Unveils World’s First Performance Shoe Made From AMSilk’s Biosteel Fiber". Planegg & New York, NY. 2016-11-18
Sygnis AG. (11/18/16). "Press Release: Sygnis AG to Present at Upcoming Investor Conferences". Madrid & Heidelberg. 2016-11-18
Horizon Discovery Group plc. (11/17/16). "Press Release: Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications". Lausanne & Cambridge. 2016-11-17
next pagenext page 1 2 3 ... 29 30 31 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

» top